Holen Sie sich die Stockscreener-App
96.01
0.10%
-0.0858
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$96.10
Offen:
$96.02
24-Stunden-Volumen:
1.02M
Relative Volume:
0.24
Marktkapitalisierung:
$46.69B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
173.91
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
+4.28%
1M Leistung:
+17.65%
6M Leistung:
+22.79%
1J Leistung:
+45.90%
1-Tages-Spanne:
$95.47
$96.62
1-Wochen-Bereich:
$91.75
$97.16
52-Wochen-Spanne:
$65.15
$97.16
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
96.04 | 46.72B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
244.09 | 171.71B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
22.30 | 15.52B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
49.60 | 14.95B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
56.85 | 11.02B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Ventas price soarsForecast today20-07-2026 - Economies.com
SEB Asset Management AB Takes Position in Ventas, Inc. $VTR - MarketBeat
California Public Employees Retirement System Trims Stock Position in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Purchases 55,339 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Holdings Lifted by Dorsey Wright & Associates - MarketBeat
Ventas stock stays supported by rent growth and steady guidance - ad-hoc-news.de
Bank of New York Mellon Corp Sells 31,263 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock holds steady as senior housing recovery supports cash flows - ad-hoc-news.de
Form 4 Ventas Inc For: 17 July By Investing.com - Investing.com Nigeria
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas (VTR) director Maurice Smith gets dividend-equivalent stock units - Stock Titan
Dividend-linked stock units credited to Ventas (VTR) director Sumit Roy - Stock Titan
Ventas (NYSE: VTR) credits director 71.6150 dividend units - Stock Titan
Ventas (VTR) director receives 48.5130 dividend-equivalent share units at $95.0400 - Stock Titan
Ventas (NYSE: VTR) director Barnes awarded 71.615 dividend-equivalent units - Stock Titan
Ventas stock trades steady as healthcare REIT focuses on senior housing recovery and dividend stabil - ad-hoc-news.de
Ventas Inc. (VTR) Q1 2026 Earnings: EPS Falls Short of Estimates Despite Positive Stock ReactionConsensus Miss Rate - dars.gov.et
Illinois Municipal Retirement Fund Sells 13,389 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock rises on steady 2026 earnings outlook - ad-hoc-news.de
Ventas Inc stock hits all-time high at 94.84 USD By Investing.com - Investing.com South Africa
Ventas Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Ventas (VTR) Lifts Annualized Dividend 8.3% As Earnings Growth Supports Payout - simplywall.st
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Ventas Inc stock hits all-time high at 94.84 USD - Investing.com
Wells Fargo Keeps Their Buy Rating on Ventas (VTR) - The Globe and Mail
VENTAS INC : JEFFERIES RAISES TARGET PRICE TO $109 FROM $100 - Moomoo
Ventas (NYSE:VTR) Reaches New 1-Year HighStill a Buy? - MarketBeat
Ventas (VTR) Could Be a Great Choice - Yahoo Finance
Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating - marketscreener.com
Is Ventas stock outperforming the Dow? - MSN
Ventas stock reflects diversified healthcare real estate strategy - ad-hoc-news.de
Why Welltower’s Growth Story Might Outrun Its Rich Valuation - Investing.com
Principal Financial Group Inc. Sells 63,314 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock reflects steady healthcare REIT positioning as senior housing demand grows - ad-hoc-news.de
Ventas stock reflects steady healthcare real estate demand - ad-hoc-news.de
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Stake in Ventas, Inc. $VTR - MarketBeat
Candriam S.C.A. Boosts Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT (NYSE:VTR) - Seeking Alpha
Azzad Asset Management Inc. ADV Invests $2.18 Million in Ventas, Inc. $VTR - MarketBeat
Here's what to expect from Ventas’ next earnings report - MSN
BMO Capital Remains a Buy on Ventas (VTR) - The Globe and Mail
Ventas Inc. stock underperforms Friday when compared to competitors - MarketWatch
Precision Trading with Ventas Inc. (VTR) Risk Zones - Stock Traders Daily
Barclays Initiates Ventas Inc(VTR.US) With Hold Rating, Announces Target Price $99 - 富途牛牛
Scotiabank Adjusts Price Target on Ventas to $93 From $88 - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Has $186.12 Million Stake in Ventas, Inc. $VTR - MarketBeat
Resona Asset Management Co. Ltd. Has $24.64 Million Holdings in Ventas, Inc. $VTR - MarketBeat
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $100 - Moomoo
Ventas Inc. (VTR) Sees Slight Dip Amid Broader Real Estate PressuresUpthrust Pattern - dars.gov.et
Swedbank AB Boosts Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. focuses on senior housing rebound as a healthcare REIT member of the S&P 500 index - Ad Hoc News
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ventas Inc-Aktie (VTR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RAKOWICH WALTER C | Director |
May 14 '26 |
Sale |
90.20 |
1,152 |
103,915 |
28,349 |
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):